Tscan Therapeutics Inc (TCRX) with a beta value of 1.07 appears to be a promising investment opportunity.
Tscan Therapeutics Inc (NASDAQ: TCRX) on Thursday, soared 10.77% from the previous trading day, before settling in for the closing price of $1.30. Within the